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Evaluation of the Biodurability of
Polyurethane-Covered Stent 
Using a Flow Phantom
Objective: To evaluate the biodurability of the covering material in retrievable
metallic stents covered with polycarbonate polyurethane.
Materials and Methods: Using a peristaltic pump at a constant rate of 1ml/min,
bile was recirculated from a reservoir through a long tube containing four stents.
Each of these was removed from the system every two weeks and a radial tensile
strength test and scanning electron microscopy (SEM) were performed. Each
stent, removed at 2, 4, 6 and 8 weeks, was compared with a control stent not
exposed to bile juice.
Results: Gross examination showed that stents were intact at 2 weeks, but at
4, 6 and 8 weeks cracks were observed. The size of these increased gradually in
accordance with the duration of exposure, and at 8 weeks several large holes in
the polyurethane membrane were evident. With regard to radial tensile strength,
extension and peak load at break were 84.47% and 10.030 N/mm, 54.90% and
6.769 N/mm, 16.55% and 2.452 N/mm, 11.21% and 1.373 N/mm at 0, 2, 4 and 6
weeks, respectively. Scanning electron microscopy at 2 weeks revealed intermit-
tent pitting and cracking, and examination at 4, 6 and 8 weeks showed that the
size of these defects was gradually increasing.
Conclusion: When the polyurethane membrane was exposed to bile,
biodegradation was first observed at week two and increased gradually according
to the duration of exposure. 
etallic stent placement has been increasingly used for the palliation of ob-
structive jaundice due to malignant or benign disease. In a benign biliary
stricture, long-term stent patency is the most important factor to be con-
sidered, as the patients have a long life expectancy(1). If metallic stents are placed in a
patient with a benign biliary stricture, it is rather difficult to extract the stent transhep-
atically and, in addition, surgery is generally not feasible because of dense endolumi-
nal or periductal fibrotic and adhesive changes (1, 2). According to previous reports,
the main cause of recurrence is late stent occlusion due to tissue ingrowth (3, 4). In or-
der to prevent late stent obstruction, covered self-expanding metallic stents have been
designed. They not only have the potential to solve the problem of tissue ingrowth,
but can also overcome the difficulties associated with the removal of a stent which is
misplaced or becomes dysfunctional (5). We hypothesized that in a benign biliary stric-
ture, removal of the covered stent when improvement was apparent would give good
results and lead to improved long-term stent patency. To facilitate removal, the stent
was covered with a polycarbonate polyurethane solution and a drawstring was posi-
tioned at its proximal end. We noticed that the biodurability of the covering material
was a very important factor in retrieval. If the material is biodegraded, tissue will grow
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Minto the stent, making it difficult to remove.
The purpose of our study was to determine the biodura-
bility of the covering material in retrievable metallic stents.
MATERIALS AND METHODS
Stents used in our experiment were woven eight times
from a single thread of 0.2-mm-diameter nitinol wire fila-
ment in a tubular configuration. The stent has eight points
on the upper and lower end portions, the wire filament
crossing spirally in an unengaged manner. One segment of
the wire filament runs alternately on and under other seg-
ments, which are arranged in a direction opposite to that of
the segment in such a way that a number of meshes are
formed by the crossing points of the segments. To prevent
tissue ingrowth through the stent wires, the stent was cov-
ered by dipping in a 12% polyurethane solution
(Chronoflex; Cardiotech International, Woburn, Mass.,
U.S.A.). To provide a firmer covering on the ends of the
stent, these were covered with 100% nylon mesh and then
dipped in the polyurethane solution. To facilitate stent re-
movable, a drawstring made of nylon monofilament was
attached to its upper inner margin (Fig. 1). 
The experimental perfusion system consisted of a bile
reservoir, a long plastic tube including four stents, and a
peristaltic pump (Fig. 2). The stents were placed in the tube
using a 12-F home-made introducer set. Human bile was
used for this study and 1,000 ml bile was replaced every
day. Fresh bile was collected from one to three patients us-
ing T-tube or percutaneous transhepatic biliary drainage.
Using a peristaltic pump, bile was circulated at a constant
rate of 1ml/min. 
The bile reservoir was cleansed using normal saline
every two weeks. After 2, 4, 6 and 8 weeks, each stent was
removed from the tube connected with the perfusion sys-
tem using a home-made retrievable hook wire. A stent not
exposed to bile (0-week stent) was used for control purpos-
es. First, each stent was observed grossly, and patency and
degree of cracking of the covering material was assessed.
Second, a radial tensile strength test was performed using
standard equipment and operating procedures. The test
piece was 10 mm long and was threaded over a split pin
assembly and loaded into the machine (Universal Testing
Machine LRX, Lloyd Instruments, Ltd.). Jaw separation
was 50mm/min, and extension and peak load at break
were recorded. Third, a 5 5 mm section of each stent was
cut, and this was coated with 200Aof platinium prior to
scanning electron microscopy (SEM) (JEOL JSM80A
SEM, Tokyo, Japan). Magnification varied, but for objec-
tive comparison, each biliary stent was always observed at
a constant magnification of  1,600.
RESULTS
Insertion of the stents into the long tube was accom-
plished easily, and during the experimental period bile was
circulated from the reservoir to the tube containing the
stents at a constant rate of 1ml/min.
Gross examination showed that the stents were intact at
2 weeks, but showed cracks at 4, 6 and 8 weeks. These in-
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Fig. 1. A polyurethane-covered, retrievable, expandable metallic
stent. 
Fig. 2. Experimental settings of a perfusion system composed of
a bile reservoir (1), long plastic tube (2) and peristaltic pump (3).
Fig. 3. Gross photograph of stent removed after eight weeks (as-
terisks : holes).creased gradually according to the duration of exposure,
and at 8 weeks several large holes were observed in the
polyurethane membrane (Fig. 3).
With regard to radial tensile strengths, extension and
peak load at break were 84.47% and 10.030 N/mm,
54.90% and 6.769 N/mm, 16.55% and 2.452 N/mm,
11.21% and 1.373N/mm at 0, 2, 4 and 6 weeks, respec-
tively. Because of the large holes observed in the mem-
brane at week 8, the radial tensile strength test was not
performed at that time (Fig. 4).
Initial SEM of the stent showed no pitting or cracking,
but SEM at two weeks revealed that these phenomena
were already present and subsequent periodic examination
showed that the size of the pits and cracks was gradually
increasing. For comparison, a constant magnification of
1,600 was used (Fig. 5).
DISCUSSION
Iatrogenic injuries are the most common cause of benign
biliary stricture (6, 7). Although the incidence of post-la-
paroscopic cholecystectomy stricture in experienced cen-
ters is less than 1%, there has nevertheless been a 5- to 10-
fold increase in the incidence of strictures when compared
with the open cholecystectomy era (8). In cases not involv-
ing surgery, the stricture may be secondary to inflammato-
ry obstruction, gallstone erosion into the main bile duct, a
pericholedochal abscess, external blunt trauma, or a com-
plication of pancreatitis (9).
For benign biliary strictures, surgical repair is the treat-
ment of choice. For the experienced surgeon, the ‘first at-
tempt’ success rate is 78 88%; the procedures offering the
greatest chance of success are choledoco- or hepaticoje-
junostomy with a Roux-en-Y jejunal loop (7). Balloon di-
latation of biliary strictures represents a natural evolution
of percutaneous transhepatic biliary drainage and has de-
veloped as a curative procedure when surgery fails to pre-
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Fig. 4. Graph shows peak load and extension at break of covered
material according to the duration of exposure to bile.
Fig. 5. SEM photomicrographs of polyurethane-covered, retrievable expandable metallic stent after exposure to bile (1,600 ) (A: 0
week, B: 2 weeks, C: 4 weeks, D: 6 weeks, E: 8 weeks). Comparison between each specimen at constant magnification showed that the
pits and cracks which developed became gradually larger in accordance with the duration of exposure.vent obstructive jaundice caused by recurrent stenosis.
Balloon dilatation, however, is usually not effective where
benign biliary stricture is due to other causes, especially
where chronic inflammatory processes such as pancreatitis
and sclerosing cholangitis are involved (8). Rossi et al. re-
ported that 70 of their patients with benign biliary stric-
tures underwent percutaneous balloon dilatation and stent-
ing (9). The reported patency rate in patients without scle-
rosing cholangitis was 96%, while for those with secondary
sclerosing cholangitis, the rate was 33%. The average fol-
low-up was 23 (range 3 72) months. Patients with anasto-
motic strictures (n=44), iatrogenic strictures (n=28), and
strictures associated with sclerosing cholangitis (n=17) who
had undergone percutaneous balloon dilatation showed pa-
tency rates after 36 months or more of 67%, 76% and
42%, respectively (10).
Many researchers have attempted the insertion of biliary
endoprostheses, including expandable metallic stents, in
patients with benign biliary stricture. Metallic stenting in
18 patients with post-surgical benign biliary strictures was
performed by Maccioni et al., who reported that the over-
all patency rate after three-year follow up was 68.7% (1).
They concluded that when surgical correction is no longer
recommended, balloon dilatation and catheter stenting is
the treatment of choice. The only indication for the use of
metallic stents is failure to respond to percutaneous treat-
ment, and in this group of patients, metallic stents have
been the only remaining way of maintaining patency of the
biliary tree without a permanent drainage catheter. Yoon
et al. used metallic stents in the treatment of 23 patients
with benign biliary strictures associated with recurrent
pyogenic cholangitis (2). Primary stent patency rates for all
patients at 6, 12, 24 and 36 months were 92%, 75%, 67%
and 46%, respectively. They concluded that metallic stents
in patients with biliary strictures associated with recurrent
pyogenic cholangitis often have a high occlusion rate and
that for long-term treatment, stents are not usually success-
ful. Because of dense endoluminal or periductal fibrotic
and adhesive changes, surgery is usually more difficult for
patients who have undergone stent placement than for
those who have not previously undergone this procedure,
and in such cases, bypass rather than curative surgery is
thus usually necessary. In patients with some probability of
future curative surgery, metallic stenting is an option which
must be carefully weighed, but if the metallic stents are re-
trievable, problems such as poor results of long-term pa-
tency and the difficulty of surgery after stent placement
may be surmounted (2). 
The ideal prosthesis must be completely biocompatible
and stable within the biologic environment and must have
a diameter similar to that of the stented segment, though
small enough to be easily inserted. Self-expandable metal-
lic stents best meet these requirements but are limited by
the impossibility of removal should the stent be misplaced
or become dysfunctional, and are subject to ingrowth of
the tumor or reactive tissue from the stented wall. Many
reports have suggested mucosal hyperplasia and inflamma-
tory reactive change in the ductal wall as possible causes of
late stent obstruction in patients with benign biliary stric-
tures (1, 2), and in order to overcome these limitations, dif-
ferent synthetic plastic coverings have been proposed (5,
12). Polyurethanes, with their extensive structure/property
diversity, are one of the most bio- and blood-compatible
materials known today. These materials played a major
role in the development of many medical devices ranging
from catheters to total artificial heart, but are affected by
certain in-vivo degradation mechanisms. Poly(ester)ure-
thanes, for example, are subject to hydrolytic degradation
and are no longer used in long-term implanted devices.
While hydrolytically stable, they are subject to oxidative
degradation in several forms, including environmental
stress cracking and metal ion oxidation. In in-vitro qualifi-
cation tests and in-vivo experiments, recently developed
polycarbonate polyurethane was more biostable than
poly(ether)urethanes (11).
Several researchers have investigated the biodurability
of polycarbonate polyurethane, finding that due to the ox-
idative stability of the carbonate linkage, biodegradation in
polycarbonate polyurethanes after 10 weeks of in-vivo
treatment was less than in polyether polyurethanes (13).
After an in-vivo study, Severini et al. described the bio-
compatibility, efficacy and stability of the metallic, self-ex-
panding Gianturco-Rosch biliary Z-stent covered with
polycarbonate polyurethane. Stents were implanted in the
common bile duct of pigs, and after 1, 3 and 6 months,
both their metallic structure and polymeric coating were
intact (12). 
We designed experiments to determine whether polycar-
bonate polyurethane is really bio-compatible or bio-stable
in a biliary environment, and our findings differed from
those of Severini et al. At 8 weeks there were several large
holes in the polyurethane membrane, indicating that if a
large rupture of the membrane occurred in a clinical situa-
tion, tissue ingrowth into the stent lumen would develop
after 8 weeks. Radial tensile strength testing showed rapid-
ly decreasing extension and peak load at break after the
first two weeks, thus indicating that biodegradation of the
polyurethane membrane began early after exposure to
bile. In addition, SEM showed that the amount of pitting
and cracking increased gradually with exposure to bile.
Our experiments suffer from several limitations, however.
First, an in-vitro model was used. Second, other factors af-
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such as physical stress or infection, were not considered.
Third, the point at which tissue ingrowth into the stent lu-
men occurred was not determined.
In conclusion, our experimental study showed that poly-
carbonate polyurethane membrane was not biostable in a
biliary environment. We suggest two possible causes of
biodegradation of the membrane. First, bile salts, with a
pH of 7.8 8.6, are alkaline, and this may have led to
changes in the chemical composition of the polycarbonate
polyurethane membrane and its subsequent biodegrada-
tion. Second, bile salts in the intestinal tract act as emulsi-
fiers or detergents, decreasing the surface tension of fat
particles in the food and allowing the agitation in the in-
testinal tract to break the fat globules into minute particles.
This emulsifying or detergent action of bile salts might
have contributed to the biodegradation of the polycarbon-
ate polyurethane membrane. It remains unclear, however,
whether the experimental finding can be transferred to the
clinical situation of benign biliary obstruction. To transfer
these results clinically, more experimental and clinical
studies must be performed.
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